Altropane: Filed an IND to begin a trial this quarter. The trial will include 10 normal volunteers and 10 patients with established Parkinson's.

Boston Life Sciences Inc. (BLSI), Waltham, Mass. Product: Altropane, radiolabeled small molecule that binds to the dopamine transporter Indication: Imaging agent to assess loss of dopamine receptors ...